{"entity":{"type":"insider","cik":"0001598099","url":"/insider/0001598099","json_url":"/insider/0001598099.json","name":"Bodick Neil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":22,"first":"2015-02-26","last":"2020-01-07","span_basis":"filed_date"},"name_variants":[{"name":"Bodick Neil","source":"filing","n_filings":22,"first_seen":"2015-02-26","last_seen":"2020-01-07"}],"transactions":[{"id":3146608,"accession":"0001209191-20-002271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002271","line_url":"/filing/0001209191-20-002271#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3851.0,"shares_display":"3,851","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":100153.0,"shares_owned_after_display":"100,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-07","scope":"insider"},{"id":7920115,"accession":"0001209191-19-002070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-002070","line_url":"/filing/0001209191-19-002070#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":746.0,"shares_display":"746","price_per_share":12.36,"price_display":"12.36","price_state":"stated","total_value":9220.56,"total_display":"9,220.56","total_whole":"9,221","shares_owned_after":64782.0,"shares_owned_after_display":"64,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":6824991,"accession":"0001209191-18-040937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-040937","line_url":"/filing/0001209191-18-040937#line-2","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16492.0,"shares_display":"16,492","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":412300.0,"total_display":"412,300.00","total_whole":"412,300","shares_owned_after":62307.0,"shares_owned_after_display":"62,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-03","filed_date":"2018-07-03","scope":"insider"},{"id":6824987,"accession":"0001209191-18-040937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-040937","line_url":"/filing/0001209191-18-040937#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33508.0,"shares_display":"33,508","price_per_share":25.1042,"price_display":"25.10","price_state":"stated","total_value":841191.5336,"total_display":"841,191.53","total_whole":"841,192","shares_owned_after":78799.0,"shares_owned_after_display":"78,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-03","scope":"insider"},{"id":5255644,"accession":"0001209191-17-062387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-062387","line_url":"/filing/0001209191-17-062387","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2700.0,"shares_display":"2,700","price_per_share":24.486014814814816,"price_display":"24.49","price_state":"stated","total_value":66112.24,"total_display":"66,112.24","total_whole":"66,112","shares_owned_after":64605.0,"shares_owned_after_display":"64,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2017-11-22","scope":"insider","n_lines":2},{"id":9270331,"accession":"0001209191-17-033947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-033947","line_url":"/filing/0001209191-17-033947","is_derivative":false,"issuer_cik":"0001598099","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001598099","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6830.0,"shares_display":"6,830","price_per_share":18.95285739385066,"price_display":"18.95","price_state":"stated","total_value":129448.016,"total_display":"129,448.02","total_whole":"129,448","shares_owned_after":59937.0,"shares_owned_after_display":"59,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-19","scope":"insider","n_lines":2},{"id":4627065,"accession":"0001209191-17-033047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-033047","line_url":"/filing/0001209191-17-033047","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6830.0,"shares_display":"6,830","price_per_share":18.95285739385066,"price_display":"18.95","price_state":"stated","total_value":129448.016,"total_display":"129,448.02","total_whole":"129,448","shares_owned_after":40807.0,"shares_owned_after_display":"40,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider","n_lines":2},{"id":9270329,"accession":"0001209191-17-033946","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-033946","line_url":"/filing/0001209191-17-033946","is_derivative":false,"issuer_cik":"0001598099","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001598099","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":28.2264,"price_display":"28.23","price_state":"stated","total_value":141132.0,"total_display":"141,132.00","total_whole":"141,132","shares_owned_after":59937.0,"shares_owned_after_display":"59,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-17","filed_date":"2017-05-19","scope":"insider","n_lines":2},{"id":5280065,"accession":"0001209191-17-027362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-027362","line_url":"/filing/0001209191-17-027362","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":28.2264,"price_display":"28.23","price_state":"stated","total_value":141132.0,"total_display":"141,132.00","total_whole":"141,132","shares_owned_after":46137.0,"shares_owned_after_display":"46,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-17","filed_date":"2017-04-18","scope":"insider","n_lines":2},{"id":9270327,"accession":"0001209191-17-033944","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033944","line_url":"/filing/0001209191-17-033944#line-1","is_derivative":false,"issuer_cik":"0001598099","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001598099","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.4077,"price_display":"20.41","price_state":"stated","total_value":102038.5,"total_display":"102,038.50","total_whole":"102,039","shares_owned_after":59937.0,"shares_owned_after_display":"59,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-05-19","scope":"insider"},{"id":4255929,"accession":"0001209191-17-021860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021860","line_url":"/filing/0001209191-17-021860#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.4077,"price_display":"20.41","price_state":"stated","total_value":102038.5,"total_display":"102,038.50","total_whole":"102,039","shares_owned_after":50937.0,"shares_owned_after_display":"50,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-20","scope":"insider"},{"id":9270326,"accession":"0001209191-17-033941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033941","line_url":"/filing/0001209191-17-033941#line-1","is_derivative":false,"issuer_cik":"0001598099","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001598099","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.1515,"price_display":"19.15","price_state":"stated","total_value":95757.5,"total_display":"95,757.50","total_whole":"95,758","shares_owned_after":59937.0,"shares_owned_after_display":"59,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-24","filed_date":"2017-05-19","scope":"insider"},{"id":5309752,"accession":"0001209191-17-014734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-014734","line_url":"/filing/0001209191-17-014734#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.1515,"price_display":"19.15","price_state":"stated","total_value":95757.5,"total_display":"95,757.50","total_whole":"95,758","shares_owned_after":55937.0,"shares_owned_after_display":"55,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-24","filed_date":"2017-02-27","scope":"insider"},{"id":4194212,"accession":"0001209191-17-005210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-005210","line_url":"/filing/0001209191-17-005210#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.3494,"price_display":"18.35","price_state":"stated","total_value":91747.0,"total_display":"91,747.00","total_whole":"91,747","shares_owned_after":60937.0,"shares_owned_after_display":"60,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-20","filed_date":"2017-01-23","scope":"insider"},{"id":3140276,"accession":"0001209191-16-156534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-156534","line_url":"/filing/0001209191-16-156534#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.4628,"price_display":"18.46","price_state":"stated","total_value":184628.0,"total_display":"184,628.00","total_whole":"184,628","shares_owned_after":65937.0,"shares_owned_after_display":"65,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-21","filed_date":"2016-12-22","scope":"insider"},{"id":2282786,"accession":"0001209191-16-122292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-122292","line_url":"/filing/0001209191-16-122292#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":850.0,"shares_display":"850","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":8500.0,"total_display":"8,500.00","total_whole":"8,500","shares_owned_after":75937.0,"shares_owned_after_display":"75,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-20","scope":"insider"},{"id":3127490,"accession":"0001209191-16-121787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-121787","line_url":"/filing/0001209191-16-121787#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":21420.0,"total_display":"21,420.00","total_whole":"21,420","shares_owned_after":75087.0,"shares_owned_after_display":"75,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":3173808,"accession":"0001209191-16-121360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-121360","line_url":"/filing/0001209191-16-121360#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":9.6,"price_display":"9.60","price_state":"stated","total_value":7680.0,"total_display":"7,680.00","total_whole":"7,680","shares_owned_after":72987.0,"shares_owned_after_display":"72,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-17","filed_date":"2016-05-18","scope":"insider"},{"id":2206979,"accession":"0001209191-16-120979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-120979","line_url":"/filing/0001209191-16-120979","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":9.22,"price_display":"9.22","price_state":"stated","total_value":11525.0,"total_display":"11,525.00","total_whole":"11,525","shares_owned_after":71937.0,"shares_owned_after_display":"71,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-17","scope":"insider","n_lines":2},{"id":8745894,"accession":"0001209191-15-026544","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-026544","line_url":"/filing/0001209191-15-026544","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":25.27875,"price_display":"25.28","price_state":"stated","total_value":101115.0,"total_display":"101,115.00","total_whole":"101,115","shares_owned_after":72437.0,"shares_owned_after_display":"72,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-16","scope":"insider","n_lines":2},{"id":8900625,"accession":"0001209191-15-025053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-025053","line_url":"/filing/0001209191-15-025053#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":24.2637,"price_display":"24.26","price_state":"stated","total_value":97054.8,"total_display":"97,054.80","total_whole":"97,055","shares_owned_after":74937.0,"shares_owned_after_display":"74,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-10","filed_date":"2015-03-11","scope":"insider"},{"id":8669364,"accession":"0001209191-15-023233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-023233","line_url":"/filing/0001209191-15-023233#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":23.4475,"price_display":"23.45","price_state":"stated","total_value":93790.0,"total_display":"93,790.00","total_whole":"93,790","shares_owned_after":78937.0,"shares_owned_after_display":"78,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-05","scope":"insider"},{"id":8574084,"accession":"0001209191-15-019296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-019296","line_url":"/filing/0001209191-15-019296#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001598099","owner_name":"Bodick Neil","owner_display_name":"Bodick Neil","owner_url":"/insider/0001598099","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":22.4415,"price_display":"22.44","price_state":"stated","total_value":89766.0,"total_display":"89,766.00","total_whole":"89,766","shares_owned_after":82937.0,"shares_owned_after_display":"82,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-26","filed_date":"2015-02-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Officer (Chief Scientific Officer)","n_filings":22,"first_seen":"2015-02-26","last_seen":"2020-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001598099","retrieved_at":"2026-08-25T23:18:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}